SRD ClinMax was founded with joint venture by prominent Japanese CRO，SRD Co., Ltd., and a China based CRO，ClinMax.
With offices in South San Francisco, Tokyo, and Beijing, SRD (Supporting of Research & Development) provides consulting and one-stop services to pharmaceutical and medical device companies for their research and development needs, from clinical trial design, data management, to data analysis and reporting.
The combination of successful experiences and local influences of SRD Co.(in Japan) and ClinMax (in China) puts SRD ClinMax in a unique position for helping pharmaceutical and medical device companies who want to expand market across Pacific Ocean.
SRD ClinMax is a full-service Clinical Research Organization (CRO) providing clinical trial management, regulatory consulting, and site/patient management services across the United States, Japan, and China.
What makes SRD ClinMax different from other CROs?
Our joint-venture structure combines Japanese precision with Chinese efficiency and U.S. expertise — giving clients a seamless, cross-regional approach to clinical research and regulatory success.
Who can benefit from SRD ClinMax’s services?
We work with pharmaceutical, biotechnology, and medical device companies seeking reliable partners for international clinical research and regulatory submissions.
Where is SRD ClinMax located?
We operate globally with offices in South San Francisco (USA), Tokyo (Japan), and Beijing (China), enabling direct local support for projects across major life-science markets.